CN

Current Neuropharmacology

Current Neuropharmacology is a journal in neuropharmacology with ISSN (Print) 1570-159X and ISSN (Online) 1875-6190. It publishes Volume 24 in 2026, has a current Impact Factor of 5.3, a 5-year Impact Factor of 7.4, and a CiteScore of 10.0. Open access articles are also available on ScienceDirect.

Looking to publish in Current Neuropharmacology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Existing customer login
Subject Neurosciences, Pharmacology & Pharmacy
Impact Factor 5.3
Quartile Q1
Open Access Type Hybrid
ISSN 1570-159X
eISSN 1875-6190
Invitation Only No
Cost Range Publication is supported by an Article Processing Charge (APC), typically paid by the author's institution, funding body, or the authors themselves.

Submission Instructions

Current Neuropharmacology accepts the following article types. Click on an article type to view submission instructions.

Review Articles

Cover Letter A signed copyright letter must be submitted by the corresponding author on behalf of all co-authors. The copyright letter must include signatures from all contributing authors, and all co-authors must declare full responsibility for the manuscript contents including any AI-generated content.
Abstract Review Articles must include a structured abstract. Abstract must not exceed 250 words. Abstract must be structured with explicit bold subheadings.
Manuscript Review Articles must be 6000-10000 words, excluding figures, structures, photographs, schemes, and tables. Review Articles must be divided into Title, Title page, Structured Abstract, Graphical Abstract, Keywords, Text Organization, Conclusion, List of Abbreviations (if any), Consent for Publication, Conflict of Interest, Acknowledgements, References, Appendices, Figures/Illustrations (if any), Chemical Structures (if any), Tables (if any), and Supportive/Supplementary Material (if any). Manuscripts must include a graphical abstract submitted separately, 6 to 8 keywords, an Authors' Contribution paragraph with a CRediT author statement, a conflict-of-interest summary statement, and disclosure of any significant AI use.
References Review Articles must include 100 or more references. References should be submitted preferably in ACS or Vancouver style. References must be cited in the text with numbers in square brackets and the bibliography must be complete, accurate, and fully formatted before submission.
Figures & Tables Illustrations and tables must be embedded in the text at their appropriate placement in the manuscript, while the graphical abstract must be submitted separately. Figures and tables must be numbered consecutively in order of citation, each table must include a self-explanatory title or caption, and figure legends and captions must be provided.
Reformat to Current Neuropharmacology using Livewrite Premium

Mini-Reviews

Cover Letter A signed copyright letter must be submitted with the manuscript. The corresponding author must submit the copyright letter on behalf of all co-authors, and all co-authors must sign a declaration accepting full responsibility for all manuscript contents including any AI-generated content.
Abstract An abstract is required. Abstract must not exceed 250 words. Abstract must be structured with explicit bold subheadings.
Manuscript Mini-Reviews must be 3000-6000 words, excluding figures, structures, photographs, schemes, and tables. Section headings must be numbered sequentially and start with the introduction. The manuscript must include a graphical abstract submitted separately, 6 to 8 keywords, an Authors' Contribution paragraph with a CRediT author statement, a conflict of interest statement, and disclosure of any significant use of AI tools.
References Mini-Reviews must include 75 or more references. References should be prepared preferably in ACS or Vancouver style. References must be cited in the text with numbers in square brackets and the reference list must exclude abstracts, unpublished data, and personal communications.
Figures & Tables Illustrations and tables must be embedded in the text at their appropriate placement in the manuscript. Each table must include a self-explanatory title or caption, and each figure must be numbered consecutively and include a legend or caption.
Reformat to Current Neuropharmacology using Livewrite Premium

Systematic Reviews

Cover Letter Cover Letter requirements are not specified.
Abstract A structured abstract is required for Systematic Reviews. Abstract must not exceed 250 words. Abstract must be structured. Abstract should use subheadings such as Introduction/Objective, Methods, Results, Discussion, and Conclusion, and registered systematic reviews must include the registration number as the last line of the abstract.
Manuscript Manuscript must be 4000–6000 words, excluding figures, structures, photographs, schemes, and tables. Manuscript must address the methods used for selecting, locating, extracting, and synthesizing data. Manuscript must include 6 to 8 keywords, a graphical abstract, conflict of interest summary statement, an Authors' Contribution paragraph, a CRediT author statement, and disclosure of any significant AI tool use.
References Systematic Reviews must include 100 or more references. References should be submitted preferably in ACS or Vancouver style. References must be cited in the text using square-bracketed numbers and listed as complete and fully formatted entries.
Figures & Tables Figures and tables must be embedded in the text at their appropriate placement in the manuscript. Each table must include a self-explanatory title or caption, and each figure must include a legend or caption and be numbered consecutively in order of appearance.
Reformat to Current Neuropharmacology using Livewrite Premium

Research Articles

Cover Letter A signed copyright letter must be submitted with the manuscript by the corresponding author on behalf of all co-authors. The copyright letter must include declarations that all authors approved the submission and publication of all versions of the manuscript and that all co-authors take full responsibility for the manuscript contents, including any AI-generated content.
Abstract Research Articles must include a structured abstract. The structured abstract must not exceed 250 words. The abstract must be structured. The structured abstract should use subheadings such as Introduction/Objective, Methods, Results, Discussion, and Conclusion.
Manuscript Research Articles must be 4000-6000 words, excluding figures, structures, photographs, schemes, and tables. The main text must be organized as Introduction, Materials and Methods, Results, Discussion, and Conclusion, and Research Articles must begin with the title page and abstract followed by the main text. The manuscript must include a graphical abstract, keywords, a List of Abbreviations if any, an Authors' Contribution paragraph with a CRediT author statement, conflict of interest disclosures, and disclosure of significant AI tool use in the manuscript.
References Research Articles must include 75 or more references. References should be submitted preferably in ACS or Vancouver style. References must be cited in the text using square-bracketed numbers and the reference list must exclude abstracts, unpublished data, and personal communications.
Figures & Tables Figures and tables must be embedded in the text at the appropriate place where they are first discussed. Figures must be numbered consecutively with legends or captions, and tables must be numbered sequentially in Arabic numerals and include a self-explanatory title or caption.
Reformat to Current Neuropharmacology using Livewrite Premium

Randomized Drug Clinical Trial Studies

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must not exceed 250 words. Abstract must use explicit bold subheadings. The trial registry name, registration identification number, and registry URL must be included at the end of the abstract.
Manuscript Manuscript must be 4000–6000 words excluding figures, structures, photographs, schemes, and tables. Manuscript must clearly state an objective or hypothesis, design and methods, essential features of interventions, main outcome measures, main results, a comment section addressing study limitations and context, conclusions, and a "Randomization and Masking" section within Methods. Manuscript must include a graphical abstract, 6 to 8 keywords, an Authors' Contribution paragraph with a CRediT author statement, a conflict of interest summary statement, disclosure of significant AI use, and trial protocols with the submission.
References References must total 50 or more. References should be submitted preferably in ACS or Vancouver style. References must be cited in the text with square-bracketed numbers and listed in finalized, fully formatted numerical order.
Figures & Tables Figures and tables must be embedded in the manuscript text at the appropriate place and cited in sequence. Each figure must include a legend or caption and each table must include a self-explanatory title or caption.
Reformat to Current Neuropharmacology using Livewrite Premium

Short Communications

Cover Letter A signed copyright letter must be submitted with the manuscript by the corresponding author on behalf of all co-authors.
Abstract Abstract must not exceed 250 words. Abstract must be structured with explicit bold subheadings.
Manuscript Short Communications must be 2000-3000 words excluding figures, structures, photographs, schemes, and tables. Manuscript must include a graphical abstract submitted separately with text not exceeding 30 words, 6 to 8 keywords, an Authors' Contribution paragraph, a CRediT author statement, a conflict of interest statement, and disclosure of any significant AI use.
References Short Communications must include 25 or more references. References should be submitted preferably in ACS or Vancouver style. References must be cited in the text using square-bracketed numbers and listed as complete, accurate, fully formatted entries.
Figures & Tables Illustrations and tables must be embedded in the text at their appropriate placement in the manuscript, while the graphical abstract must be submitted separately. Each table must include a self-explanatory title or caption, and each figure must have a legend or caption and be numbered consecutively in order of appearance.
Reformat to Current Neuropharmacology using Livewrite Premium

Recent Publications

Differential Serum NGF and BDNF Levels in People Living with HIV According to Antiretroviral Therapy, Historical and Current Viroimmunological Condition: A Pilot Study

Luca Maddaloni, Pamela Rosso, Elena Fico, Letizia Santinelli, Carmen Falvino, Marco Ridolfi, Giampiero Ferraguti, Giancarlo Ceccarelli, Claudio Maria Mastroianni, Guido Antonelli, Carolina Scagnolari, Gabriella d'Ettorre, Marco Fiore

10.2174/011570159x476515260713105822
View Publication

Targeting NMDA Receptor Pathways in Alzheimer's Disease, From Cellular Mechanisms to Treatment Strategies

Md Sirajuddin Khan, Astik Manju Ashesh, Mithul V. Mammen, Abdulrahman Alhusaini, Talha Jawaid, Md Sayeed Akhtar, Khalid Orayj, Israr Ansari, Dileep Kumar, Ajay Kumar

10.2174/011570159x474645260731070203
View Publication

Association of Hypnotic Drug Use and Infectious Disease: Observational Associations and Target-Specific Genetic Evidence

Wanting Huang, Wei Guo, Jiazhen Zheng, Huiying Zhang, Zhihao Guo, Hui Xia, Hui Yan, Yuqing Li, Jihui Zhang, Sizhi Ai, Dewei Shang

10.2174/011570159x481446260730094320
View Publication

P2X7 Receptor Modulators from Natural Products: Their Actions on Inflammatory and Painful Chronic Diseases

Raíssa Mariaan dos Stos Galvão, Ana Luisa Palhares de Miranda, Robson Xavier Faria

10.2174/011570159x338338250318062435
View Publication

Metformin in Neurodegenerative Diseases: Mechanisms and Therapeutic Implications

Aveline P. Langmead, Breauna A. Keane, Jive A. Jacob, Kota V. Ramana

10.2174/011570159x476604260704180015
View Publication

Frequently asked questions

How long does it take to publish?

Authors are usually requested to resubmit revised papers within 15 days. The time frame for revision may vary from one to four weeks depending on the revision required. QUICK TRACK allows online publication within 2 weeks of receipt of the final approved galley proofs, with total publication time from first receipt of the manuscript to online publication of 10 weeks, subject to acceptance and author revisions within one week.

Reformat to Current Neuropharmacology using Livewrite Premium

Is a cover letter required?

A signed copyright letter must be submitted with the manuscript by the corresponding author on behalf of all co-authors.

Reformat to Current Neuropharmacology using Livewrite Premium

What are the publication costs?

Subscription journal with open access articles.

Reformat to Current Neuropharmacology using Livewrite Premium

Research Topics

Neuroscience and Neuropharmacology Research Tryptophan and brain disorders Neurotransmitter Receptor Influence on Behavior Alzheimer's disease research and treatments Neuroinflammation and Neurodegeneration Mechanisms Cholinesterase and Neurodegenerative Diseases Stress Responses and Cortisol Treatment of Major Depression Parkinson's Disease Mechanisms and Treatments Diverse Scientific and Economic Studies Pain Mechanisms and Treatments Nicotinic Acetylcholine Receptors Study Schizophrenia research and treatment Epilepsy research and treatment Cannabis and Cannabinoid Research 14-3-3 protein interactions Receptor Mechanisms and Signaling Mitochondrial Function and Pathology Cancer Mechanisms and Therapy Ion channel regulation and function Neurological disorders and treatments Bipolar Disorder and Treatment Neurological Disease Mechanisms and Treatments Neurogenesis and neuroplasticity mechanisms Pharmacological Receptor Mechanisms and Effects

Related Journals

NT
Neuromodulation Technology at the Neural Interface Elsevier BV
NR
Neurochemical Research Springer Science+Business Media
IJ
International Journal of Pharmaceutics Elsevier BV
CT
Clinical Therapeutics Elsevier BV
DD
Drug Design Development and Therapy Dove Medical Press
JO
Journal of Psychopharmacology SAGE Publishing